The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector (384975)
ARTG Name
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector
Product name
HADLIMA adalimumab 40 mg/0.4 mL solution for injection in PushTouch auto-injector
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Adalimumab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information